Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit [version 2; peer review: 2

HIGHLIGHTS

• who: See referee reports and collaborators from the University of California, San Diego, La Jolla, CA, USA have published the research work: Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit [version 2; peer review: 2, in the Journal: (JOURNAL) of 12/Nov/2018
• what: This is a review of hypnotic drug risks and benefits reassessing and updating advice presented to the Commissioner of the Food and Drug Administration (United States FDA). The AASM suggested use of the most popular hypnotics with which this review is concerned, even though conceding that . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.